In support of Chiasma, a biopharmaceutical company working to bring a new oral treatment for acromegaly (a rare pituitary disease), JPA created a multifaceted campaign aimed to engage patients and prompt them to talk to their doctor about new medical options. JPA used elements of digital, social and earned media to reach the key audience with real-life stories anchored by a powerful call to action.
PUTTING THE CARE IN RARE
Agency: JPA HEALTH COMMUNICATIONS
2016 | B2C